Lucerno Dynamics has developed a breakthrough system that can detect and quantify the dynamic uptake of radiolabeled biomarkers in tissue quickly, safely, and inexpensively. Any therapeutic or diagnostic procedure that can use a radiolabeled biomarker is a candidate to use Lucerno technology to help quantify and visualize the result in the target tissue. Identified uses include oncology, Alzheimer’s, kidney function, auto-immune, and more.
2015
John Cambier
Active
Decisions
Future of Work
https://lucerno.com/
Location: United States, North Carolina, Cary